过去一年中添加的文章，按日期排序
The causal relationship between non-alcoholic fatty liver disease, hypertension, and cardiovascular diseases: implications for future research
T Maeda - Hypertension Research, 2024 - nature.com
8 天前 - … liver (NAFL) and non-alcoholic steatohepatitis (NASH) and is … not only the progression
of liver disease, such as cirrhosis and … Insulin resistance (IR) is another main mechanism …
of liver disease, such as cirrhosis and … Insulin resistance (IR) is another main mechanism …
Daphnetin Alleviates Nash by Modulating Lipid Metabolism, Bile Acids and Gut Microbiota in Mcd Diet Mice
X Miao, P Luo, Y Zhao, C Xie, J Wang… - Bile Acids and Gut … - papers.ssrn.com
13 天前 - … data to explore the possible mechanisms on how 119 … the more severe the insulin
resistance. TG contains the 441 … in non-alcoholic fatty liver disease and its associated liver …
resistance. TG contains the 441 … in non-alcoholic fatty liver disease and its associated liver …
P-Synephrine Ameliorates Non-Alcoholic Fatty Liver Disease by Regulating Liver-Adipose Axis Via Ampk/Nf-Kappa B Pathway
WF Cai, QC Chen, Q Ni, SX Lin, C Yang, Y Yi… - … -Alcoholic Fatty Liver … - papers.ssrn.com
16 天前 - … The protective effects of p-synephrine against NAFLD and its mechanisms were …
, liver and inguinal white adipose tissue (iWAT) in mice. HFD-caused insulin resistance and …
, liver and inguinal white adipose tissue (iWAT) in mice. HFD-caused insulin resistance and …
[PDF][PDF] Ursolic acid: A promising therapeutic agent for NAFLD via inhibition of SPP1-induced Th17 cell differentiation
SJ Kim, J Hyun - Clinical and Molecular Hepatology, 2024 - e-cmh.org
16 天前 - … insulin resistance, hepatic steatosis, inflammation, and … First, the mechanisms by
which ursolic acid operates in the liver … non-alcoholic fatty liver disease. Clin Mol Hepatol 2024. …
which ursolic acid operates in the liver … non-alcoholic fatty liver disease. Clin Mol Hepatol 2024. …
[HTML][HTML] АКТУАЛЬНЫЕ ВОПРОСЫ СОВРЕМЕННОГО ЛЕЧЕНИЯ НЕАЛКОГОЛЬНОЙ ЖИРОВОЙ БОЛЕЗНИ ПЕЧЕНИ
AI Rubenovna, JN Mamasolievna - JOURNAL OF BIOMEDICINE AND …, 2024 - tadqiqot.uz
20 天前 - … Non-alcoholic fatty liver disease (NAFLD), as one of the … is currently the most common
liver disease worldwide. Currently, … mechanisms and modern methods of treating NAFLD, …
liver disease worldwide. Currently, … mechanisms and modern methods of treating NAFLD, …
Hepatic steatosis and its associations with acute and chronic liver diseases
AB Koenig, A Tan, H Abdelaal, F Monge… - Alimentary …, 2024 - Wiley Online Library
20 天前 - … Hepatic insulin resistance is a key feature of MASLD. Seipin is … definition of
non-alcoholic fatty liver disease (NAFLD) was … with underlying mechanism of insulin resistance …
non-alcoholic fatty liver disease (NAFLD) was … with underlying mechanism of insulin resistance …
ANTIDIABETIC DRUGS IN THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE: A LITERATURE REVIEW
JN Mamasolievna - Gospodarka i Innowacje., 2024 - … -pl.openconference.us
23 天前 - … the main pathogenetic mechanisms and modern methods of treating NAFLD, paying
… for the development of the disease are associated with the state of insulin resistance and, …
… for the development of the disease are associated with the state of insulin resistance and, …
Modulation of mitochondrial dynamism in kupffer cells impacts systemic metabolism
F Fantini, L Da Dalt, A Moregola… - Cardiovascular …, 2024 - academic.oup.com
29 天前 - … of Non-Alcoholic Fatty Liver Disease (NAFLD). The … lipid profile, glucose and insulin
sensitivity assays, and complete … to understand the molecular mechanisms underlying these …
sensitivity assays, and complete … to understand the molecular mechanisms underlying these …
[HTML][HTML] Stem Cell Res
A Thomas, VJ Gallicchio - Stem Cell Research Associated with Obesity - genesispub.org
Pin1 Exacerbates Non-Alcoholic Fatty Liver Disease by Enhancing Its Activity through Binding to ACC1
Y Jin, Z Shangguan, J Pang, Y Chen, S Lin… - International Journal of …, 2024 - mdpi.com
31 天前 - … an inhibitory effect against hepatic steatosis, inflammation, insulin resistance, and
fibrosis in … and downstream signaling pathway proteins, exacerbating non-alcoholic fatty liver …
fibrosis in … and downstream signaling pathway proteins, exacerbating non-alcoholic fatty liver …